VEGF and VEGF receptors are pivotal proteins in modulating angiogenesis, and inhibiting the VEGF/VEGF-R pathway was proved to be efficient in cancer therapy (Sitohy et al., 2012). The gene discussed is VEGFA; the disease is cancer.